T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,594,867 shares of HAE stock, worth $83.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,594,867
Previous 2,195,569
27.36%
Holding current value
$83.3 Million
Previous $140 Million
14.72%
% of portfolio
0.08%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding HAE
# of Institutions
335Shares Held
53.3MCall Options Held
540KPut Options Held
306K-
Black Rock Inc. New York, NY5.96MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$259 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$223 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$112 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$98.4 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.68B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...